Titus Gary
Insider CIK 1298900 · IMUC Chairman and Secretary, Director · SCLN Senior VP Finance & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2016-06-17 | 2016-06-21 | 156,750 | — | $0 | 156,750 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2015-09-18 | 2015-09-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award | 2015-09-18 | 2015-09-22 | 10,000 | — | $0 | 28,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2015-06-26 | 2015-06-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2014-06-13 | 2014-06-17 | 47,500 | — | $0 | 47,500 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2013-12-20 | 2013-12-20 | 100 | $0.78 | $78 | 100 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2013-12-20 | 2013-12-20 | 17,900 | $0.78 | $14.0K | 18,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2013-09-20 | 2013-09-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2013-03-07 | 2013-03-11 | 11,342 | — | $0 | 11,342 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2013-03-07 | 2013-03-11 | 21,945 | — | $0 | 21,945 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2012-06-15 | 2012-06-18 | 36,954 | — | $0 | 98,017 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2012-06-15 | 2012-06-18 | 29,624 | — | $0 | 68,393 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2012-06-15 | 2012-06-18 | 29,624 | $0.95 | $28.1K | 66,719 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2012-06-15 | 2012-06-18 | 36,954 | $6.99 | $258.3K | 37,095 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2012-06-15 | 2012-06-18 | 36,954 | $0.95 | $35.1K | 74,049 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2012-06-15 | 2012-06-18 | 29,624 | $6.99 | $207.1K | 37,095 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2012-06-14 | 2012-06-18 | 15,029 | — | $0 | 134,971 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2012-06-14 | 2012-06-18 | 15,029 | $0.95 | $14.3K | 52,124 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2012-06-14 | 2012-06-18 | 15,029 | $7.05 | $106.0K | 37,095 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | P Buy | 2012-05-31 | 2012-06-18 | 261 | $3.84 | $1.0K | 37,095 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2012-05-14 | 2012-05-16 | 9,357 | — | $0 | 28,070 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2012-05-14 | 2012-05-16 | 9,357 | — | $0 | 36,834 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2012-03-15 | 2012-04-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | P Buy | 2012-02-29 | 2012-04-04 | 241 | $3.78 | $911 | 27,477 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | P Buy | 2011-11-30 | 2012-04-04 | 241 | $3.78 | $911 | 27,236 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | P Buy | 2011-08-31 | 2012-04-04 | 229 | $3.98 | $911 | 26,995 | SEC↗ |